Glioblastoma Multiforme of Brain Clinical Trials

11 recruiting

Glioblastoma Multiforme of Brain Trials at a Glance

12 actively recruiting trials for glioblastoma multiforme of brain are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Phase 1 with 4 trials, with the heaviest enrollment activity in Rotterdam, Bern, and Boston. Lead sponsors running glioblastoma multiforme of brain studies include Jasper Gerritsen, Baylor College of Medicine, and Baptist Health South Florida.

Browse glioblastoma multiforme of brain trials by phase

Treatments under study

About Glioblastoma Multiforme of Brain Clinical Trials

Looking for clinical trials for Glioblastoma Multiforme of Brain? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Glioblastoma Multiforme of Brain trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Glioblastoma Multiforme of Brain clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 1

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

GlioblastomaGliomaGlioblastoma Multiforme of Brain
Tetragon Biosciences Ltd30 enrolled3 locationsNCT07464925
Recruiting
Phase 1

GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma

Glioblastoma Multiforme of Brain
Baylor College of Medicine27 enrolled1 locationNCT06815432
Recruiting
Phase 2

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

Brain CancerGlioblastomaGlioblastoma Multiforme+4 more
Baptist Health South Florida190 enrolled1 locationNCT06991101
Recruiting
Early Phase 1

Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma

GlioblastomaRecurrent GlioblastomaGlioblastoma Multiforme of Brain
Abramson Cancer Center at Penn Medicine15 enrolled2 locationsNCT06613841
Recruiting
Not Applicable

Deciphering Mechanisms Underlying Cancer Immunogenicity

Ovarian CancerCervical CancerHead and Neck Cancer+2 more
Institut Claudius Regaud1,100 enrolled3 locationsNCT03958240
Recruiting
Phase 1

Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy

Glioblastoma Multiforme (GBM)GBMGlioma+5 more
Sunnybrook Health Sciences Centre10 enrolled1 locationNCT07179328
Recruiting
Not Applicable

Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)

Brain CancerGlioblastomaGBM+5 more
Northwell Health10 enrolled1 locationNCT05979064
Recruiting

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

GlioblastomaGlioblastoma MultiformeGlioblastoma, IDH-wildtype+5 more
Jasper Gerritsen464 enrolled8 locationsNCT06283927
Recruiting

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

Brain NeoplasmsGlioblastomaGlioblastoma, IDH-wildtype+6 more
Erasmus Medical Center225 enrolled8 locationsNCT06273176
Recruiting

The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

GlioblastomaGlioblastoma MultiformeGlioblastoma, IDH-wildtype+2 more
Jasper Gerritsen564 enrolled8 locationsNCT06146725
Recruiting
Not Applicable

The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.

Brain NeoplasmsBrain TumorBrain Cancer+4 more
Jasper Gerritsen246 enrolled5 locationsNCT03861299
Recruiting
Phase 1

Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®

Glioblastoma Multiforme of BrainGlioma, Sarcomatous
Photolitec LLC30 enrolled1 locationNCT05363826